Research programme: anti-infectives - Wockhardt
Alternative Names: Ketolides - Wockhardt; Oxas - Wockhardt; WCK 2370; WCK 2664; WCK 2832; WCK 2924; WCK 3023; WCK 919; WCK-1734; WCK-4086; WCK-4897; WCK-4918Latest Information Update: 02 Jan 2023
At a glance
- Originator Wockhardt
- Class Ketolides; Oxazolidinones
- Mechanism of Action DNA gyrase inhibitors; DNA topoisomerase IV inhibitors; Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bacterial infections; Gram-positive infections; Methicillin-resistant Staphylococcus aureus infections; Skin and soft tissue infections
- Discontinued Gram-negative infections; Nosocomial infections; Urinary tract infections
Most Recent Events
- 27 Dec 2022 Discontinued for Nosocomial infections in India (unspecified route)
- 27 Dec 2022 Discontinued for Urinary tract infections in India (unspecified route)
- 27 Dec 2022 Discontinued - Preclinical for Gram-negative infections in India (unspecified route)